Basagine 3ml Inj

Description

Uses Of Basagine 3ml Inj

• Basagine 3ml Inj is a solution for injection used as antidiabetic agent.
• Insulin Glargine is a biosynthetic long-acting, human insulin analogue administered subcutaneously to lower the excess blood-glucose-level.
• It is synthesized by using recombinant DNA technology and a special laboratory strain of non-pathogenic Escherichia coli

Side Effects

• Irritation, pain, or redness at the injection site
• Weight gain
• Nervousness
• Chills
• Sleepiness
• Headache
• Blurred vision
• Shaking
• Irregular heartbeat
• Weakness
• Muscle cramps

How To Use Basagine 3ml Inj

• Take a look at the leaflet for patients as well as Instructions for Use, if they are available at Your pharmacist prior to beginning using your drug and every when you receive refills.
• If you have questions or concerns, consult your doctor, diabetes educator or pharmacist. 
• Follow all package directions for proper use/injection/storage of the particular type of device/insulin you are using.
• Your medical expert will show you how to inject the medication.
• If the details are unclear, speak with your physician or pharmacist.
• Do not inject insulin cold since it could be painful.
• The insulin container that you are currently using should be kept at the room temperature (see the Storage section).
• Cleanse your hands prior to taking insulin measurements and injecting it.
• Before you use, examine the product’s contents for visible particles that are thickening or clumps.
• If there are any remove the container.
• Insulin glargine must be colorless and clear.
• To prevent damage to the insulin, you should not shake the container.

How Effective Is Basagine 3ml Inj?

• Basagine 3ml Injection is made up of Insulin Glargine that is part of a class of drugs called long-acting insulins. 
• Basagine 3ml is effective because it replaces the insulin the body produces.
• It also prevents kidney damage, blindness sexual issues and loss of limbs and nerve issues by regulating the blood sugar levels.

Interactions

• Drugs that may enhance the blood-glucose-lowering effect and increase susceptibility to hypoglycaemia
• Oral antidiabetic agents
• Angiotensin converting enzyme (ACE) inhibitors
• Disopyramide
• Fibrates
• Fuoxetine
• Monoamine oxidase (MAO) inhibitors
• Pentoxifylline
• Propoxyphene
• Salicylates
• Sulfonamide antibiotics
• Drugs that may reduce the blood-glucose-lowering effect include corticosteroids
• Danazol
• Diazoxide
• Diuretics
• Glucagon

• Monitoring glucose levels is vital for any patient receiving insulin therapy.
•  Modifications to insulin regimens must be done with caution and only under the supervision of a medical professional.
• If there is a lack of glucose control, or a tendency to hypoglycaemic and hyperglycaemic events and the patient’s compliance of the recommended treatment plan as well as the injection site, injection technique and any other factors that affect the patient must be considered prior to the decision of dose adjustments.
• The requirements for insulin can change in the context of emotional or physical illness
• These situations could require an increased metabolic surveillance and perhaps, additional measures (e.g. dose adjustments and test for ketones on the urine).